E-LIB Suche - Ergebnisse für: Stephan Stilgenbauer

1

Prognostic and predictive role of gene mutations in chronic..:

Eugen Tausch ; Philipp Beck ; Richard F. Schlenk...
Haematologica. 105 (2020) 10 - p. 2440-2447 , 2020

Link: https://doi.org/10.3324/..

2

Bendamustine, followed by ofatumumab and ibrutinib in chron..:

Paula Cramer ; Julia v. Tresckow ; Sandra Robrecht...
Haematologica. 106 (2020) 2 - p. 543-554 , 2020

Link: https://doi.org/10.3324/..

3

Clinical activity of abemaciclib in patients with relapsed ..:

Franck Morschhauser ; Kamal Bouabdallah ; Stephan Stilgenbauer...
Haematologica. 106 (2020) 3 - p. 859-862 , 2020

Link: https://doi.org/10.3324/..

4

Comparative analysis of targeted next-generation sequencing..:

Lesley-Ann Sutton ; Viktor Ljungström ; Anna Enjuanes...
Haematologica. 106 (2020) 3 - p. 682-691 , 2020

Link: https://doi.org/10.3324/..

5

Identification of the atypically modified autoantigen Ars2 ..:

Lorenz Thurner ; Sylvia Hartmann ; Moritz Bewarder...
Haematologica. 106 (2020) 8 - p. 2224-2232 , 2020

Link: https://doi.org/10.3324/..

6

Combining ibrutinib and checkpoint blockade improves CD8+ T..:

Bola S. Hanna ; Haniyeh Yazdanparast ; Yasmin Demerdash...
Haematologica. 106 (2020) 4 - p. 968-977 , 2020

Link: https://doi.org/10.3324/..

7

Prognostic impact of prevalent chronic lymphocytic leukemia..:

Sonia Jaramillo ; Andreas Agathangelidis ; Christof Schneider...
Haematologica. 105 (2019) 11 - p. 2598-2607 , 2019

Link: https://doi.org/10.3324/..

8

Mantle Cell Lymphoma Is Characterized by Inactivation of th..:

Claudia Schaffner ; Irina Idler ; Stephan Stilgenbauer..
Proceedings of the National Academy of Sciences of the United States of America. 97 (2000) 6 - p. 2773-2778 , 2000

Link: https://www.jstor.org/st..

9

The addition of bortezomib to rituximab, high-dose cytarabi..:

Fischer, Luca ; Jiang, Linmiao ; Dürig, Jan...
Leukemia. 38 (2024) 6 - p. 1307-1314 , 2024

Link: https://doi.org/10.1038/..

10

Venetoclax resistance in acute lymphoblastic leukemia is ch..:

Enzenmüller, Stefanie ; Niedermayer, Alexandra ; Seyfried, Felix...
Cell Death & Disease. 15 (2024) 7 - p. , 2024

Link: https://doi.org/10.1038/..

11

Six-year follow-up and subgroup analyses of a phase 2 trial..:

Stilgenbauer, Stephan ; Tausch, Eugen ; Roberts, Andrew W....
Blood Advances. 8 (2024) 8 - p. 1992-2004 , 2024

Link: https://doi.org/10.1182/..

12

Venetoclax Initiation in Chronic Lymphocytic Leukemia: Inte..:

Anderson, Mary Ann ; Walewska, Renata ; Hackett, Fidelma...
Cancers. 16 (2024) 5 - p. 980 , 2024

Link: https://doi.org/10.3390/..

13

ERIC recommendations for TP53 mutation analysis in chronic ..:

Malcikova, Jitka ; Pavlova, Sarka ; Baliakas, Panagiotis...
Leukemia. 38 (2024) 7 - p. 1455-1468 , 2024

Link: https://doi.org/10.1038/..

14

Ibrutinib combined with immunochemotherapy with or without ..:

Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva...
The Lancet. 403 (2024) 10441 - p. 2293-2306 , 2024

Link: https://doi.org/10.1016/..

15

An Updated Comparison of Overall Survival with Brexucabtage..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S359-S360 , 2024

Link: https://doi.org/10.1016/..